Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Other Assets
Abbott Laboratories
Other Assets Peer Comparison
Competitive Other Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Other Assets
$23.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
9%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Assets
$24.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
36%
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Assets
$14.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
10%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Assets
$1.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
Stryker Corp
NYSE:SYK
|
Other Assets
$15.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Assets
$348.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
See Also
What is Abbott Laboratories's Other Assets?
Other Assets
23.7B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Other Assets amounts to 23.7B USD.
What is Abbott Laboratories's Other Assets growth rate?
Other Assets CAGR 10Y
9%
Over the last year, the Other Assets growth was 3%.